All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits

Toxicology and Applied Pharmacology

Volumn 141, Issue 2, 1996, Pages 456-472

  Tembe, E A ^a   Honeywell, R ^a   Buss, N E ^a   Renwick, A G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOIC ACID; RETINOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; EMBRYO; FETUS; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; RAT; TERATOGENICITY;

EID: 0030447251     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0312     Document Type: Article

References (55)

1. Allenby, G., Bocquel, M-T., Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J. F., Chambon, P., and Levin, A. A. (1993). Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA 90, 30-34.
2. Apfel, C., Crettaz, M., Siegenthaler, G., and Hunziker, W. (1991). Synthetic retinoids: Differential binding to retinoic acid receptors. In Retinoids: 10 Years On, (J.-H. Saurat, Ed.), pp. 110-120. Karger, Basel.
3. Bailey, J. S., and Siu, C-H. (1988). Purification and partial characterisation of a novel binding protein for retinoic acid from neonatal rat. J. Biol. Chem. 263, 9326-9332.
4. Barua, A. B., and Olson, J. A. (1986). Retinoyl β-glucuronide: An endogenous compound in human blood. Am. J. Clin. Nutr. 43, 481-485.
5. 3H]retinoyl β-glucuronide and its metabolism in rats in vivo. Biochem. J. 263, 403-409.
6. Biesalski, H. K. (1989). Comparative assessment of the toxicology of vitamin A and retinoids in man. Toxicology 57, 117-161.
7. Buss, N. E., Tembe, E. A., Prendergast, B. D., Renwick, A. G., and George, C. F. (1994). The teratogenic metabolites of vitamin A in women following supplements and liver. Hum. Exp. Toxicol. 13, 33-43.
8. CMO (1990). Letter from Chief Medical Officer to health care professionals in the United Kingdom. PL/CMO (90) 11. Advice confirmed in the 1993 Annual Report of the Committee on Toxicity of Chemicals in Food Consumer Products and the Environment, pp. 22-23. HMSO, London (1994).
9. Cohlan, S. O. (1953). Excessive intake of vitamin A as a cause of congenital abnormalities in the rat. Science 117, 535-536.
10. Colburn, W. A., Vane, F. M., and Shorter, H. J. (1983). Pharmacokinetics of isotretinoin and its major blood metabolite following a single oral dose to man. Eur. J. Clin. Pharmacol. 24, 689-694.
11. Collins, M. D., Eckhoff, C., Chahoud, I., Bochert, G., and Nau, H. (1992). 4-Methylpyrazole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans-retinoic acid in the mouse. Arch. Toxicol. 66, 652-659.
12. Collins, M. D., Tzimas, G., Hummler, H., Bürgin, H., and Nau, H. (1994). Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid and retinyl palmitate following daily administration in rats. Toxicol. Appl. Pharmacol. 127, 132-144.
13. Collins, M. D., Tzimas, G., Bürgin, H., Hummler, H., and Nau, H. (1995). Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: Differential metabolism and transplacental kinetics in rat and rabbit. Toxicol. Appl. Pharmacol. 130, 9-18.
14. Creech Kraft, J., and Juchau, M. R. (1993). Conceptional biotransformation of microinjected retinoids. Correlations with dysmorphogenic activities. Ann. NY Acad. Sci. 678, 338-340.
15. Creech Kraft, J., Löfberg, B., Chahoud, I., Bochert, G., and Nau, H. (1989). Teratogenicity and placental transfer of all-trans, 13-cis, 4-oxo-all-trans, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice. Toxicol. Appl. Pharmacol. 100, 162-176.
16. Creech Kraft, J., Eckhoff, C., Kochhar, D. M., Bochert, G., Chahoud, I., and Nau, H. (1991a). Isotretinoin (13-cis-retinoic acid) metabolism, cis-trans isomerisation, glucuronidation and transfer to the mouse embryo: Consequences for teratogenicity. Teratogen. Carcinogen. Mutagen. 11, 21-30.
17. Creech Kraft, J., Slikker, W., Bailey, J. R., Roberts, L. G., Fischer, B., Wittfoht, W., and Nau, H. (1991b). Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the Cynomolgus monkey and the identification of 13-cis and all-trans-retinoyl-β-glucuronides. A comparison to one human case study with isotretinoin. Drug Metab. Dispos. 19, 317-324.
18. Dekker, E-J., Vaessen, M-J., van den Berg, C., Timmermans, A., Godsave, S., Holling, T., Nieuwkoop, P., van Kessel, A. G., and Durston, A. (1994). Overexpression of a cellular retinoic acid binding protein (xCRABP) causes anteroposterior defects in developing Xenopus embryos. Development 120, 973-985.
19. Eckhoff, C., Löfberg, B., Chahoud, I., Bochert, G., and Nau, H. (1989). Transplacental pharmacokinetics and teratogenicity of a single oral dose of retinol (vitamin A) during organogenesis in the mouse. Toxicol. Lett. 48, 171-184.
20. Eckhoff, C., Chari, S., Kromka, M., Staudner, H., Juhasz, L., Rudiger, H., and Agnish, N. (1994). Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits. Toxicol. Appl. Pharmacol. 125, 34-41.
21. Geelen, J. A. G. (1979). Hypervitaminosis A induced teratogenesis. CRC Crit. Rev. Toxicol. 6, 351-375.
22. Gunning, D. B., Barua, A. B., and Olson, J. A. (1993). Comparative teratogenicity and metabolism of all-trans retinoic acid, all-trans retinoyl β-glucose, and all-trans retinoyl β-glucuronide in pregnant Sprague-Dawley rats. Teratology 47, 29-36.
23. Hummler, H., Korte, R., and Hendrickx, A. G. (1990). Induction of malformations in the Cynomolgus monkey with 13-cis-retinoic acid. Teratology 42, 263-272.
24. Kalin, J. R., Wells, M. J., and Hill, D. L. (1984). Effects of phenobarbital, 3-methylcholanthrene and retinoid pretreatment on disposition of orally administered retinoids in mice. Drug Metab. Dispos. 12, 63-67.
25. Khoo, K. C., Reik, D., and Colburn, W. A. (1982). Pharmacokinetics of isotretinoin following a single oral dose. J. Clin. Pharmacol. 22, 395-402.
26. Kistler, A. (1981). Teratogenesis of retinoic acid in rats: Susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide. Teratology 23, 25-31.
27. Kistler, A., and Howard, W. B. (1990). Testing retinoids for teratogenicity in vivo. Methods Enzymol. 190, 433-437.
28. Klug, S., Creech Kraft, J., Wildi, E., Merker, H.-J., Persaud, T. V. N., Nau, H., and Neubert, D. (1989a). Influence of 13-cis and all-trans retinoic acid on rat embryonic development in vitro: Correlation with isomerisation and drug transfer to the embryo. Arch. Toxicol. 63, 185-192.
29. Klug, S., Lewandowski, C., Wildi, L., and Neubert, D. (1989b). All-trans retinoic acid and 13-cis retinoic acid in the rat whole-embryo culture: Abnormal development due to the all-trans isomer. Arch. Toxicol. 63, 440-444.
30. Kochhar, D. (1990). Quantification of embryonic retinoic acid derived from maternally administered retinol. Methods Enzymol. 190, 317-325.
31. Kochhar, D. M., and Penner, J. D. (1987). Developmental effects of isotretinoin and 4-oxo-isotretinoin: The role of metabolism in teratogenicity. Teratology 36, 67-75.
32. Kochhar, D. M., Penner, J. D., and Tellone, C. I. (1984). Comparative teratogenic activities of two retinoids: Effects on palate and limb development. Teratogen. Carcinogen. Mutagen. 4, 377-387.
33. Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, J. A. W., Lott, I. T., Richard, J. M., and Sun, S. C. (1985). Retinoic acid embryopathy. N. Engl. J. Med. 313, 837-841.
34. Löfberg, B., Reiners, J., Spielmann, H., and Nau, H. (1990). Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: A possible model for the extended elimination phase in human therapy. Dev. Pharmacol. Ther. 15, 45-51.
35. Lucek, R. W., and Colburn, W. A. (1985). Clinical pharmacokinetics of the retinoids. Clin. Pharmacokin. 10, 38-62.
36. Mendelsohn, C., Larkin, S., Mark, M., LeMeur, M., Clifford, J., Zelent, A., and Chambon, P. (1994). RARβ isoforms: Distinct transcriptional control by retinoic acid and specific spacial patterns of promoter activity during mouse embryonic development. Mech. Dev. 45, 227-241.
37. Morriss-Kay, G. (1993). Retinoic acid and craniofacial development: Molecules and morphogenesis. BioEssays 15, 9-15.
38. Napoli, J. L. (1993). Biosynthesis and metabolism of retinoic acid: Roles of CRBP and CRABP in retinoic acid: Roles of CRBP and CRABP in retinoic acid homeostasis. J. Nutr. 123, 362-366.
39. Nau, H. (1990). Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicity. Methods Enzymol. 190, 437-448.
40. Nau, H. (1993). Teratogenesis, transplacental pharmacokinetics, and metabolism of some retinoids in the mouse, monkey and human. In Retinoids. Progress in Research and Clinical Applications (M. A. Livrea and L. Packer, Eds.), pp. 599-616. Dekker, New York.
41. Pijnappel, W. W. M., Hendriks, H. F. J., Folkers, G. E., van den Brink, C. E., Dekker, E. J., Edelenbosch, C., van der Saag, P. T., and Durston, A. J. (1993). The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature 366, 340-344.
42. Rosa, F. W., Wilk, A. L., and Kelsey, F. O. (1986). Teratogen update: Vitamin A congeners. Teratology 33, 355-364.
43. Ross, A. C. (1993). Cellular metabolism and activation of retinoids: Roles of cellular retinoid-binding proteins. FASEB J. 7, 317-327.
44. Rothman, K. J., Moore, L. L., Singer, M. R., Nguyen, U-S. D. T., Mannino, S., and Milunsky, A. (1995). Teratogenicity of high vitamin A intake. N. Engl. J. Med. 333, 1369-1373.
45. Sass, J. O., Forster, A., Bock, K. W., and Nau, H. (1994). Glucuronidation and isomerisation of all-trans-retinoic acid and 13-cis-retinoic acid by liver microsomes of phenobarbital-or 3-methylcholanthrene-treated rats. Biochem. Pharmacol. 47, 485-492.
46. Sauerhoff, M. W., Braun, W. H., Blau, G. E., and Gehring, P. J. (1976). The dose-dependent pharmacokinetic profile of 2,4,5-trichlorophenoxyacetic acid following intravenous administration to rats. Toxicol. Appl. Pharmacol. 36, 491-501.
47. Scotter, M. J., Thorpe, S. A., Reynolds, S. L., Wilson, L. A., and Lewis, D. J. (1992). Survey of animal livers for vitamin A content. Food Addit. Contam. 9, 237-242.
48. Soprano, D. R., Harnish, D. C., Soprano, K. J., Kochhar, D. M., and Jiang, H. (1993). Correlations of RAR isoforms and cellular retinoid-binding proteins mRNA levels with retinoid-induced teratogenesis. J. Nutr. 123, 367-371.
49. Swanson, B. N., Frolik, C. A., Zaharevitz, D. W., Roller, P. P., and Sporn, M. B. (1981). Dose-dependent kinetics of all-trans-retinoic acid in rats. Plasma levels and excretion into bile, urine and faeces. Biochem. Pharmacol. 30, 107-113.
50. Turton, J. A., Willars, G. B., Haselden, J. N., Ward, S. J., Steele, C. E., and Hicks, R. M. (1992). Comparatve teratogenicity of nine retinoids in the rat. Int. J. Exp. Pathol. 73, 551-563.
51. Tzimas, G., Collins, M. D., and Nau, H. (1995). Developmental stage-associated differences in the transplacental distribution of 13-cis- and all-trans-retinoic acid as well as their glucuronides in rats and mice. Toxicol. Appl. Pharmacol. 133, 91-101.
52. Ward, S., and Morriss-Kay, G. M. (1995). Distribution of all-trans-, 13-cis- and 9-cis-retinoic acid to whole rat embryos and maternal serum following oral administration of a teratogenic dose of all-trans-retinoic acid. Pharmacol. Toxicol. 76, 196-201.
53. Webster, W. S., Johnston, M. C., Lammer, E. J., and Sulik, K. K. (1986). Isotretinoin embryopathy and the cranial neural crest: An in vivo and in vitro study. J. Craniofac. Gen. Dev. Biol. 6, 211-222.
54. Willhite, C. C., and Book, S. A. (1990). Utility of disposition data in evaluating retinoid developmental toxicity. Methods Enzymol. 190, 406-417.
55. Willhite, C. C., Wier, P. J., and Berry, D. L. (1989). Dose response and structure-activity considerations in retinoid induced dysmorphogenesis. Crit. Rev. Toxicol. 20, 113-135.